Purchase Order 75D30122P13718
Award Date 4/21/22
Potential Completion Date 5/31/23
Potential Value $99K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chamblee, GA 30341, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Vela Diagnostics USA Inc. to provide maintenance services for the Sentosa SQ HIV genotyping systems. The contract has a potential value of $100,000.00 and a period of performance ending on September 29, 2027. Vela Diagnostics USA Inc. is a global provider of integrated molecular diagnostic solutions that has previously supported federal agencies such as the Department of Veterans...
- The Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Vela Diagnostics USA Inc. for $31,206.40 to procure Sentosa SQ HIV genotyping reagent kits and consumables. This sole source award is for the FDA-approved Next Generation Sequencing (NGS) HIV-1 drug resistance assay, which Vela Diagnostics is the sole manufacturer of. The place of performance is Fairfield, New Jersey. This award is not associated with a larger contract vehicle and does not have a...
- Vela Diagnostics USA Inc. was awarded a $185,261 firm fixed-price purchase order by the Centers for Disease Control and Prevention (CDC) to provide VELA Diagnostics equipment. The CDC, a component of the Department of Health and Human Services, works to protect public health and safety through the control and prevention of disease, injury, and disability. This award was made directly without a set-aside designation and calls for the equipment to be delivered to a location in Fairfield, New...
- This definitive contract was awarded by the Centers for Disease Control and Prevention (CDC) to Vela Diagnostics USA Inc. to purchase reagents and consumables for approximately $59,500. The CDC, a component of the Department of Health and Human Services, seeks to protect public health and safety through the control and prevention of disease, injury, and disability. This firm fixed price contract supports the CDC's mission and is being performed in Chamblee, Georgia through August 1, 2023. No set...
- This federal contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 to Vela Diagnostics USA Inc., a for-profit organization, for the VELA DIAGNOSTICS VIROKEY SENTOSA requirement. The award, made on January 13, 2021, is a firm-fixed-price purchase order with a potential value of $436,564.36 and a completion date of December 31, 2021. The contract does not have a set-aside designation. Through this award, Vela Diagnostics...
- This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Vela Diagnostics USA Inc., a global provider of integrated molecular diagnostic solutions. The contract, valued at $1,439,264.40, is for the rental of a VELA SQ SENTOSA Next Generation Sequencing (NGS) System. This equipment and associated services will support critical public health initiatives through the provision of leading diagnostic technologies. The contract does not have a set-aside designation....
- This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) to Life Technologies Corporation, a prime contractor and manufacturer of scientific instruments, reagents, and consumables. The $79,005.12 firm fixed price contract is for the delivery of a QuantStudio DX with 96 Well Fast Block, a desktop genetic analysis system. This award is not associated with a set-aside program. Life Technologies has previously supported the CDC, National Institutes of Health,...
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 to Vela Diagnostics USA Inc., a for-profit organization, for the provision of laboratory testing equipment. The contract has a total small business set-aside designation and a potential value of $149,000.00. It supports the national interest action code for the Coronavirus COVID-19 response. Through past prime federal contract awards,...
- This is a federal purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to LGC Clinical Diagnostics Inc., a foreign-owned for-profit manufacturer of clinical diagnostic products. The contract, valued at $21,556.49, is for the provision of HIV Performance Panels, which are quality control tools used in clinical laboratories. The contract has a completion date of September 30, 2019 and a firm fixed price pricing type. This...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $18,854.28 contract supports the development and validation of new HIV genotyping assays that enable monitoring tools for managing the treatment of HIV-positive patients. This work does not have a set-aside designation. The contract has an ultimate completion date of August 5, 2029....
This federal contract award, with an ID of 75D30122P13718, was made by the Centers for Disease Control and Prevention (CDC) to Vela Diagnostics USA Inc. for the provision of SENTOSA SQ HIV-1 GENOTYPING ASSAY REAGENTS. The contract has a firm fixed price of $99,339.90 and a completion date of May 31, 2023. Vela Diagnostics USA Inc. is a global provider of integrated molecular diagnostic solutions for infectious diseases and cancer, and this award supports the CDC's critical public health initiatives through the provision of leading diagnostic technologies and associated equipment, supplies, and services. The contract does not have a set-aside designation.
Generated 4/2/25, 4:30 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $99.3k | 4/21/22 |